Science Explorer Back to mapMap
Discussion
Researcher · New Frontier · United States

Martin I. Freed

Martin I. Freed publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology, on topics such as Peroxisome Proliferator-Activated Receptors, Diabetes Treatment and Management and Diabetes, Cardiovascular Risks, and Lipoproteins.

OpenAlex
World rank
#689,813
of 7,710,434 ranked researchers
Rank in United States
#233,515
of 1,627,098
Works
55
Citations
5.5k
Citations per work
100.4
h-index
29
i10-index 41Top 11% in Endocrinology, Diabetes and Metabolism
Martin I. Freed

What does Martin I. Freed research?

Martin I. Freed's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (18%).

Health Sciences: 26 works · 46.5% of their workMedicine: 26 works · 46.5% of their workEndocrinology, Diabetes and Metabolism: 12 works · 21.3% of their workPhysiology: 5 works · 8.4% of their workNeurology: 3 works · 5.8% of their workOncology: 3 works · 5.8% of their workPulmonary and Respiratory Medicine: 3 works · 5.2% of their workEverything else: 19 works · 35.4% of their workLife Sciences: 10 works · 18.1% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 18.1% of their workMolecular Biology: 10 works · 18.1% of their workTHEIR WORKMartin I. Freed55works
Life Sciences18%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2646.5%
  2. Everything else1935.4%
    1. Biochemistry, Genetics and Molecular Biology1018.1%
  1. 1Endocrinology, Diabetes and Metabolism21% of their works
  2. 2Molecular Biology18% of their works
  3. 3Physiology8% of their works
  4. 4Oncology6% of their works
  5. 5Neurology6% of their works
  6. 6Pulmonary and Respiratory Medicine5% of their works

Research topics

Which keywords describe Martin I. Freed's research?

The keywords of their largest research topics: Diabetes, Obesity, Nuclear Receptors, Inflammation, Peroxisome Proliferator-Activated Receptors, PPARs, Atherosclerosis and Cardiovascular Outcomes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Diabetes342 topics
  2. Obesity342 topics
  3. Nuclear Receptors262 topics
  4. Inflammation252 topics
  5. PPARs211 topic
  6. Peroxisome Proliferator-Activated Receptors211 topic
  7. Atherosclerosis172 topics
  8. Cardiovascular Outcomes161 topic
  9. Type 2 Diabetes161 topic
  10. Cardiovascular Disease131 topic
  11. Metabolic Syndrome131 topic
  12. Oxidative Stress82 topics
  13. AMP-Activated Protein Kinase51 topic
  14. ATP-dependent Transporters51 topic
  15. Metformin51 topic
  16. Multidrug Resistance51 topic
  17. Endothelial Dysfunction41 topic
  18. Genetics41 topic
  19. Nitric Oxide41 topic
  20. Parkinson's Disease41 topic
  21. Type 1 Diabetes41 topic
  22. a-Synuclein41 topic

Where does Martin I. Freed work?

Martin I. Freed's main affiliation in the publication record is New Frontier, United States.

How many publications and citations does Martin I. Freed have?

OpenAlex counts 55 works and 5,521 citations for Martin I. Freed, an h-index of 29, ranking #689,813 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Martin I. Freed. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.